Bio-View Ltd (TLV:BIOV)
Israel · Delayed Price · Currency is ILS · Price in ILA 92.80
+3.20 (3.57%)
Jul 24, 2026, 1:44 PM IDT
Bio-View Market Cap
Bio-View has a market cap or net worth of 12.44 million as of July 24, 2026. Its market cap has decreased by -63.03% in one year.
Market Cap
12.44M
Enterprise Value
8.01M
Revenue
19.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
92.80
ChartMarket Cap Chart
Since April 3, 2006, Bio-View's market cap has decreased from 59.79M to 12.44M, a decrease of -79.20%. That is a compound annual growth rate of -7.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 12.44M | -44.43% |
| Dec 31, 2025 | 22.38M | -37.30% |
| Dec 31, 2024 | 35.69M | -21.62% |
| Dec 31, 2023 | 45.53M | -10.12% |
| Dec 29, 2022 | 50.66M | 13.09% |
| Dec 30, 2021 | 44.79M | -20.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 111.70B |
| Danel (Adir Yeoshua) | 2.69B |
| Amal Holdings A.D. | 2.48B |
| BrainsWay | 2.00B |
| Erika Carmel-Tech | 21.46M |
| XTL Biopharmaceuticals | 20.64M |
| Purple Biotech | 18.65M |
| Evogene | 17.68M |